# Helping Stroke Patients With ThermoSuit Cooling

> **NCT02453373** · NA · TERMINATED · sponsor: **Life Recovery Systems** · enrollment: 14 (actual)

## Conditions studied

- Stroke
- Brain Ischemia

## Interventions

- **DEVICE:** ThermoSuit Cooling Induction
- **DRUG:** Magnesium Sulfate
- **DRUG:** tPA
- **DRUG:** Propofol
- **DRUG:** Etomidate
- **PROCEDURE:** Neurothrombectomy

## Key facts

- **NCT ID:** NCT02453373
- **Lead sponsor:** Life Recovery Systems
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-25
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-02
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The study has achieved its objectives of showing feasibility, safety, and trend for improved mRS. FDA and LRS agreed that this study should be terminated, and that a new, PIVOTAL trial should be started.
- **Last updated:** 2023-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02453373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02453373, "Helping Stroke Patients With ThermoSuit Cooling". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02453373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
